Table I.
Characteristics | Total no. of patients, n=80 | miR-153 expression
|
P-value | |
---|---|---|---|---|
Low | High | |||
Age (years) | 0.348 | |||
≤60 | 28 | 16 | 12 | |
>60 | 52 | 24 | 28 | |
Gender | 0.813 | |||
Male | 27 | 14 | 13 | |
Female | 53 | 26 | 27 | |
Tumor margin | 0.179 | |||
Negative | 38 | 16 | 22 | |
Positive | 42 | 24 | 18 | |
Lymph node metastasis | 0.014a | |||
Absent | 43 | 16 | 27 | |
Present | 37 | 24 | 13 | |
Tumor size (cm) | 0.446 | |||
≤2 | 21 | 9 | 12 | |
>2 | 59 | 31 | 28 | |
Neural invasion | 0.496 | |||
Negative | 33 | 15 | 18 | |
Positive | 47 | 25 | 22 | |
Tumor recurrence | 0.004a | |||
None | 39 | 13 | 26 | |
Local and regional metastasis | 41 | 27 | 14 | |
Tumor differentiation | 0.024a | |||
Wel/moderate | 34 | 12 | 22 | |
Poor | 46 | 28 | 18 | |
Tumor stage | 0.001a | |||
I+II | 39 | 12 | 27 | |
III+IV | 41 | 28 | 13 |
Statistically significant. PDAC, pancreatic ductal adenocarcinoma.